6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
Top Cited Papers
Open Access
- 24 November 2017
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 41 (Supplement), S55-S64
- https://doi.org/10.2337/dc18-s006
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.Keywords
This publication has 83 references indexed in Scilit:
- Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulinEmergencias, 2012
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' DurationJAMA Internal Medicine, 2009
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesThe New England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trialBMJ, 2008
- A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesDiabetologia, 2008
- Long-Term Effect of Diabetes and Its Treatment on Cognitive FunctionThe New England Journal of Medicine, 2007